<DOC>
	<DOCNO>NCT01920867</DOCNO>
	<brief_summary>This study evaluate use autologous bone marrow derive stem cell ( BMSC ) treatment retinal optic nerve damage disease .</brief_summary>
	<brief_title>Stem Cell Ophthalmology Treatment Study</brief_title>
	<detailed_description>Eyes loss vision retinal optic nerve condition generally consider irreversible treated combination injection autologous bone marrow derive stem cell isolate bone marrow use standard medical surgical practice . Retinal condition may include degenerative , ischemic physical damage ( example may include macular degeneration , hereditary retinal dystrophy retinitis pigmentosa , stargardt , non-perfusion retinopathy , post retinal detachment . Optic Nerve condition may include degenerative , ischemic physical damage ( example may include optic nerve damage glaucoma , compression , ischemic optic neuropathy , optic atrophy ) . Injections may include retrobulbar , subtenon , intravitreal , intraocular , subretinal intravenous . Patients follow 12 month serial comprehensive eye examination include relevant imaging diagnostic ophthalmic testing .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Retinal Dystrophies</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<criteria>Have objective , document damage retina optic nerve unlikely improve OR Have objective , document damage retina optic nerve progressive AND less equal 20/40 best correct central visual acuity one eye AND/OR abnormal visual field one eye . Be least 3 month postsurgical treatment intend treat ophthalmologic disease stable . If current medical therapy ( pharmacologic treatment ) retinal optic nerve disease consider stable treatment unlikely visual function improvement ( example , glaucoma intraocular pressure stable topical medication visual field damage ) . Have potential improvement BMSC treatment minimal risk potential harm procedure . Be age 18 Be medically stable able medically clear primary care physician license primary care practitioner procedure . Medical clearance mean estimation primary care practitioner , patient reasonably expect undergo procedure without significant medical risk health . Patients capable adequate ophthalmologic examination evaluation document pathology . Patients capable willing undergo follow eye exam principle investigator ophthalmologist optometrist outline protocol . Patients capable provide informed consent . Patients may significant risk general health eye visual function undergo procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Stem Cells</keyword>
	<keyword>Bone Marrow Derived Stem Cells</keyword>
	<keyword>BMSC</keyword>
	<keyword>BMC ( Bone Marrow Cell )</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>MSC</keyword>
	<keyword>Eye Disease</keyword>
	<keyword>Eye Stem Cells</keyword>
	<keyword>Ophthalmology</keyword>
	<keyword>Ophthalmic Disease</keyword>
	<keyword>Retina</keyword>
	<keyword>Retinal Disease</keyword>
	<keyword>Macular Degeneration</keyword>
	<keyword>Age Related Macular Degeneration</keyword>
	<keyword>Myopic Macular Degeneration</keyword>
	<keyword>Geographic Atrophy</keyword>
	<keyword>Dry Macular Degeneration</keyword>
	<keyword>Wet Macular Degeneration</keyword>
	<keyword>Retinal Atrophy</keyword>
	<keyword>Retinal Dystrophy</keyword>
	<keyword>Hereditary Retinal Dystrophy</keyword>
	<keyword>Retinitis Pigmentosa</keyword>
	<keyword>Stargardt Disease</keyword>
	<keyword>Cone Dystrophy</keyword>
	<keyword>Cone Rod Dystrophy</keyword>
	<keyword>Maculopathy</keyword>
	<keyword>Optic Nerve Disease</keyword>
	<keyword>Optic Nerve Atrophy</keyword>
	<keyword>Optic Atrophy</keyword>
	<keyword>Ischemic Optic Neuropathy</keyword>
	<keyword>Optic Nerve Damage</keyword>
	<keyword>Optic Nerve Compression</keyword>
	<keyword>Compressive Optic Neuropathy</keyword>
	<keyword>Devics Syndrome</keyword>
</DOC>